Annual Income Tax
$938.00 M
+$1.73 B+218.43%
31 December 2023
Summary:
AstraZeneca annual income tax is currently $938.00 million, with the most recent change of +$1.73 billion (+218.43%) on 31 December 2023. During the last 3 years, it has risen by +$166.00 million (+21.50%). AZN annual income tax is now -71.25% below its all-time high of $3.26 billion, reached on 31 December 2009.AZN Income Tax Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Income Tax
$395.00 M
-$74.00 M-15.78%
30 September 2024
Summary:
AstraZeneca quarterly income tax is currently $395.00 million, with the most recent change of -$74.00 million (-15.78%) on 30 September 2024. Over the past year, it has increased by +$121.00 million (+44.16%). AZN quarterly income tax is now -56.64% below its all-time high of $911.00 million, reached on 30 September 2009.AZN Quarterly Income Tax Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Income Tax
$1.42 B
+$121.00 M+9.30%
30 September 2024
Summary:
AstraZeneca TTM income tax is currently $1.42 billion, with the most recent change of +$121.00 million (+9.30%) on 30 September 2024. Over the past year, it has increased by +$546.00 million (+62.33%). AZN TTM income tax is now -56.42% below its all-time high of $3.26 billion, reached on 31 December 2009.AZN TTM Income Tax Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AZN Income Tax Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +218.4% | +44.2% | +62.3% |
| 3 y3 years | +21.5% | +212.9% | +1875.0% |
| 5 y5 years | +1745.6% | +206.2% | +1700.0% |
AZN Income Tax High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +218.4% | -36.3% | +154.9% | at high | +248.4% |
| 5 y | 5 years | at high | +218.4% | -36.3% | +154.9% | at high | +248.4% |
| alltime | all time | -71.3% | +218.4% | -56.6% | +146.3% | -56.4% | +248.4% |
AstraZeneca Income Tax History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $395.00 M(-15.8%) | $1.42 B(+9.3%) |
| June 2024 | - | $469.00 M(-24.4%) | $1.30 B(+18.3%) |
| Mar 2024 | - | $620.00 M(-1100.0%) | $1.10 B(+17.3%) |
| Dec 2023 | $938.00 M(-218.4%) | -$62.00 M(-122.6%) | $938.00 M(+7.1%) |
| Sept 2023 | - | $274.00 M(+2.2%) | $876.00 M(-842.4%) |
| June 2023 | - | $268.00 M(-41.5%) | -$118.00 M(-76.4%) |
| Mar 2023 | - | $458.00 M(-469.4%) | -$499.00 M(-37.0%) |
| Dec 2022 | -$792.00 M(+108.4%) | -$124.00 M(-82.8%) | -$792.00 M(-17.3%) |
| Sept 2022 | - | -$720.00 M(+537.2%) | -$958.00 M(+62.9%) |
| June 2022 | - | -$113.00 M(-168.5%) | -$588.00 M(+125.3%) |
| Mar 2022 | - | $165.00 M(-156.9%) | -$261.00 M(-31.3%) |
| Dec 2021 | -$380.00 M(-149.2%) | -$290.00 M(-17.1%) | -$380.00 M(-627.8%) |
| Sept 2021 | - | -$350.00 M(-263.6%) | $72.00 M(-88.5%) |
| June 2021 | - | $214.00 M(+365.2%) | $624.00 M(-1.4%) |
| Mar 2021 | - | $46.00 M(-71.6%) | $633.00 M(-18.0%) |
| Dec 2020 | $772.00 M(+140.5%) | $162.00 M(-19.8%) | $772.00 M(+34.7%) |
| Sept 2020 | - | $202.00 M(-9.4%) | $573.00 M(+14.6%) |
| June 2020 | - | $223.00 M(+20.5%) | $500.00 M(+60.8%) |
| Mar 2020 | - | $185.00 M(-600.0%) | $311.00 M(-3.1%) |
| Dec 2019 | $321.00 M(-663.2%) | -$37.00 M(-128.7%) | $321.00 M(+306.3%) |
| Sept 2019 | - | $129.00 M(+279.4%) | $79.00 M(+276.2%) |
| June 2019 | - | $34.00 M(-82.6%) | $21.00 M(-73.8%) |
| Mar 2019 | - | $195.00 M(-169.9%) | $80.00 M(-240.4%) |
| Dec 2018 | -$57.00 M(-91.1%) | -$279.00 M(-493.0%) | -$57.00 M(-91.0%) |
| Sept 2018 | - | $71.00 M(-23.7%) | -$632.00 M(+4.3%) |
| June 2018 | - | $93.00 M(+60.3%) | -$606.00 M(-7.2%) |
| Mar 2018 | - | $58.00 M(-106.8%) | -$653.00 M(+1.9%) |
| Dec 2017 | -$641.00 M(-539.0%) | -$854.00 M(-980.4%) | -$641.00 M(-210.7%) |
| Sept 2017 | - | $97.00 M(+110.9%) | $579.00 M(+255.2%) |
| June 2017 | - | $46.00 M(-34.3%) | $163.00 M(+38.1%) |
| Mar 2017 | - | $70.00 M(-80.9%) | $118.00 M(-19.2%) |
| Dec 2016 | $146.00 M(-39.9%) | $366.00 M(-214.7%) | $146.00 M(-164.6%) |
| Sept 2016 | - | -$319.00 M(<-9900.0%) | -$226.00 M(-189.0%) |
| June 2016 | - | $1.00 M(-99.0%) | $254.00 M(+18.1%) |
| Mar 2016 | - | $98.00 M(-1733.3%) | $215.00 M(-11.5%) |
| Dec 2015 | $243.00 M(+2109.1%) | -$6.00 M(-103.7%) | $243.00 M(-2530.0%) |
| Sept 2015 | - | $161.00 M(-523.7%) | -$10.00 M(-90.2%) |
| June 2015 | - | -$38.00 M(-130.2%) | -$102.00 M(-2140.0%) |
| Mar 2015 | - | $126.00 M(-148.6%) | $5.00 M(-54.5%) |
| Dec 2014 | $11.00 M(-98.4%) | -$259.00 M(-475.4%) | $11.00 M(-85.3%) |
| Sept 2014 | - | $69.00 M(0.0%) | $75.00 M(-78.6%) |
| June 2014 | - | $69.00 M(-47.7%) | $350.00 M(-34.7%) |
| Mar 2014 | - | $132.00 M(-167.7%) | $536.00 M(-23.0%) |
| Dec 2013 | $696.00 M(-49.4%) | -$195.00 M(-156.7%) | $696.00 M(-42.3%) |
| Sept 2013 | - | $344.00 M(+34.9%) | $1.21 B(-12.2%) |
| June 2013 | - | $255.00 M(-12.7%) | $1.37 B(+9.0%) |
| Mar 2013 | - | $292.00 M(-7.6%) | $1.26 B(-8.4%) |
| Dec 2012 | $1.38 B(-41.0%) | $316.00 M(-38.2%) | $1.38 B(-14.1%) |
| Sept 2012 | - | $511.00 M(+262.4%) | $1.60 B(-9.8%) |
| June 2012 | - | $141.00 M(-65.4%) | $1.77 B(-25.1%) |
| Mar 2012 | - | $408.00 M(-24.6%) | $2.37 B(+1.5%) |
| Dec 2011 | $2.33 B(-19.4%) | $541.00 M(-20.9%) | $2.33 B(-4.5%) |
| Sept 2011 | - | $684.00 M(-6.9%) | $2.44 B(-0.8%) |
| June 2011 | - | $735.00 M(+97.1%) | $2.46 B(-2.6%) |
| Mar 2011 | - | $373.00 M(-42.7%) | $2.53 B(-12.7%) |
| Dec 2010 | $2.90 B | $651.00 M(-7.5%) | $2.90 B(+1.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2010 | - | $704.00 M(-12.1%) | $2.85 B(-6.8%) |
| June 2010 | - | $801.00 M(+8.2%) | $3.05 B(-2.9%) |
| Mar 2010 | - | $740.00 M(+22.9%) | $3.14 B(-3.6%) |
| Dec 2009 | $3.26 B(+27.9%) | $602.00 M(-33.9%) | $3.26 B(+1.4%) |
| Sept 2009 | - | $911.00 M(+2.2%) | $3.22 B(+6.8%) |
| June 2009 | - | $891.00 M(+3.7%) | $3.01 B(+8.7%) |
| Mar 2009 | - | $859.00 M(+54.2%) | $2.77 B(+8.7%) |
| Dec 2008 | $2.55 B(+8.3%) | $557.00 M(-21.0%) | $2.55 B(-0.2%) |
| Sept 2008 | - | $705.00 M(+8.3%) | $2.56 B(+7.0%) |
| June 2008 | - | $651.00 M(+2.0%) | $2.39 B(+4.2%) |
| Mar 2008 | - | $638.00 M(+13.5%) | $2.29 B(-2.8%) |
| Dec 2007 | $2.36 B(-5.0%) | $562.00 M(+4.7%) | $2.36 B(-3.9%) |
| Sept 2007 | - | $537.00 M(-3.1%) | $2.45 B(-2.3%) |
| June 2007 | - | $554.00 M(-21.2%) | $2.51 B(-2.1%) |
| Mar 2007 | - | $703.00 M(+6.8%) | $2.56 B(+3.3%) |
| Dec 2006 | $2.48 B(+27.6%) | $658.00 M(+10.6%) | $2.48 B(+8.6%) |
| Sept 2006 | - | $595.00 M(-2.0%) | $2.28 B(+3.7%) |
| June 2006 | - | $607.00 M(-2.1%) | $2.20 B(+3.9%) |
| Mar 2006 | - | $620.00 M(+34.2%) | $2.12 B(+9.1%) |
| Dec 2005 | $1.94 B(+67.4%) | $462.00 M(-9.9%) | $1.94 B(+5.2%) |
| Sept 2005 | - | $513.00 M(-2.3%) | $1.85 B(+14.4%) |
| June 2005 | - | $525.00 M(+18.5%) | $1.61 B(+22.4%) |
| Mar 2005 | - | $443.00 M(+21.0%) | $1.32 B(+13.6%) |
| Dec 2004 | $1.16 B(+12.4%) | $366.00 M(+30.7%) | $1.16 B(+27.4%) |
| Sept 2004 | - | $280.00 M(+21.7%) | $911.00 M(-2.8%) |
| June 2004 | - | $230.00 M(-19.3%) | $937.30 M(-2.5%) |
| Mar 2004 | - | $285.00 M(+145.7%) | $961.41 M(-6.9%) |
| Dec 2003 | $1.03 B(-12.2%) | $116.00 M(-62.1%) | $1.03 B(-14.6%) |
| Sept 2003 | - | $306.30 M(+20.5%) | $1.21 B(+5.8%) |
| June 2003 | - | $254.11 M(-28.7%) | $1.14 B(-2.9%) |
| Mar 2003 | - | $356.59 M(+21.7%) | $1.18 B(+0.0%) |
| Dec 2002 | $1.18 B(+2.1%) | $292.95 M(+22.0%) | $1.18 B(+0.3%) |
| Sept 2002 | - | $240.05 M(-16.6%) | $1.17 B(-3.3%) |
| June 2002 | - | $288.00 M(-19.1%) | $1.21 B(+1.1%) |
| Mar 2002 | - | $356.00 M(+23.2%) | $1.20 B(+4.2%) |
| Dec 2001 | $1.15 B(-11.3%) | $289.00 M(+3.2%) | $1.15 B(-12.4%) |
| Sept 2001 | - | $280.00 M(+1.8%) | $1.31 B(+0.6%) |
| June 2001 | - | $275.00 M(-10.7%) | $1.31 B(-2.3%) |
| Mar 2001 | - | $308.00 M(-31.9%) | $1.34 B(+3.0%) |
| Dec 2000 | $1.30 B(+24.0%) | $451.99 M(+65.9%) | $1.30 B(+31.3%) |
| Sept 2000 | - | $272.37 M(-10.8%) | $989.45 M(-1.0%) |
| June 2000 | - | $305.42 M(+13.3%) | $999.07 M(-0.7%) |
| Mar 2000 | - | $269.65 M(+89.9%) | $1.01 B(+36.6%) |
| Dec 1999 | $1.05 B(+16.1%) | $142.00 M(-49.6%) | $736.00 M(+23.9%) |
| Sept 1999 | - | $282.00 M(-9.6%) | $594.00 M(+90.4%) |
| June 1999 | - | $312.00 M(-1.9%) | $312.00 M(-1.9%) |
| Dec 1998 | $903.00 M(+58.3%) | - | - |
| June 1998 | - | $318.00 M(+147.7%) | $318.00 M(+147.7%) |
| Dec 1997 | $570.32 M(+4.1%) | - | - |
| Dec 1996 | $548.00 M(+32.3%) | - | - |
| Dec 1995 | $414.12 M(+26.1%) | - | - |
| June 1995 | - | $128.40 M | $128.40 M |
| Dec 1994 | $328.31 M(+17.4%) | - | - |
| Dec 1993 | $279.57 M(+1743.3%) | - | - |
| Dec 1992 | $15.17 M(-95.1%) | - | - |
| Dec 1991 | $312.49 M(+35.0%) | - | - |
| Dec 1990 | $231.47 M | - | - |
FAQ
- What is AstraZeneca annual income tax?
- What is the all time high annual income tax for AstraZeneca?
- What is AstraZeneca annual income tax year-on-year change?
- What is AstraZeneca quarterly income tax?
- What is the all time high quarterly income tax for AstraZeneca?
- What is AstraZeneca quarterly income tax year-on-year change?
- What is AstraZeneca TTM income tax?
- What is the all time high TTM income tax for AstraZeneca?
- What is AstraZeneca TTM income tax year-on-year change?
What is AstraZeneca annual income tax?
The current annual income tax of AZN is $938.00 M
What is the all time high annual income tax for AstraZeneca?
AstraZeneca all-time high annual income tax is $3.26 B
What is AstraZeneca annual income tax year-on-year change?
Over the past year, AZN annual income tax has changed by +$1.73 B (+218.43%)
What is AstraZeneca quarterly income tax?
The current quarterly income tax of AZN is $395.00 M
What is the all time high quarterly income tax for AstraZeneca?
AstraZeneca all-time high quarterly income tax is $911.00 M
What is AstraZeneca quarterly income tax year-on-year change?
Over the past year, AZN quarterly income tax has changed by +$121.00 M (+44.16%)
What is AstraZeneca TTM income tax?
The current TTM income tax of AZN is $1.42 B
What is the all time high TTM income tax for AstraZeneca?
AstraZeneca all-time high TTM income tax is $3.26 B
What is AstraZeneca TTM income tax year-on-year change?
Over the past year, AZN TTM income tax has changed by +$546.00 M (+62.33%)